Wounds that do not respond to standard of care pose a real challenge to health professionals, causing considerable patient suffering, incurring extra resource use and sapping staff morale. When all other options have failed, often the only recourse is to advanced therapies. One example is biomaterials derived from human, animal, synthetic and biosynthetic sources, which can be used for the repair and regeneration of soft tissue.
First available in the 1970s, there is no universal guidelines on best practice for their use. To fill this gap, JWC has published an international expert-opinion consensus document. Based on a panel discussion by leading clinicians, it is a game-changer. It proposes a new definition for this technology and gives it a new name — cellular, acelluar and matrix-like products, or CAMP — to better reflect recent innovations in this area.
The consensus document provides comprehensive, scientific, evidence-based information on the rationale for using CAMPs, how they interact with soft tissue to promote repair and regeneration, what treatment goals they can deliver, and how to optimise patient outcomes when using them.